Abbott Laboratories (ABT) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Abbott Laboratories, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Short-term borrowings | |
|
|
|
|
|
Trade accounts payable | |
|
|
|
|
|
Salaries, wages and commissions | |
|
|
|
|
|
Accrued rebates payable to government agencies | |
|
|
|
|
|
Accrued other rebates | |
|
|
|
|
|
All other | |
|
|
|
|
|
Other accrued liabilities | % |
% |
% |
% |
% |
|
Dividends payable | |
|
|
|
|
|
Income taxes payable | |
|
|
|
|
|
Obligation in connection with conclusion of the TAP Pharmaceutical Products Inc. joint venture | |
|
|
|
|
|
Current portion of long-term debt | |
|
|
|
|
|
Current liabilities | % |
% |
% |
% |
% |
|
Long-term debt, excluding current portion | |
|
|
|
|
|
Defined benefit pension plans and post-employment medical and dental plans for significant plans | |
|
|
|
|
|
Deferred income taxes | |
|
|
|
|
|
All other | |
|
|
|
|
|
Post-employment obligations and other long-term liabilities | % |
% |
% |
% |
% |
|
Noncurrent liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Preferred shares, one dollar par value, none issued | |
|
|
|
|
|
Common shares, without par value | |
|
|
|
|
|
Common shares held in treasury, at cost | |
|
|
|
|
|
Earnings employed in the business | |
|
|
|
|
|
Accumulated other comprehensive income (loss) | |
|
|
|
|
|
Abbott shareholders' investment | % |
% |
% |
% |
% |
|
Noncontrolling interests in subsidiaries | |
|
|
|
|
|
Total shareholders' investment | % |
% |
% |
% |
% |
|
Total liabilities and shareholders' investment | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center